LOWELL HOLDEN - 31 Mar 2023 Form 4 Insider Report for Nascent Biotech Inc. (NBIO)

Role
CFO, Director
Signature
/s/ Lowell Holden
Issuer symbol
NBIO
Transactions as of
31 Mar 2023
Net transactions value
+$40,060
Form type
4
Filing time
09 Jun 2023, 15:28:28 UTC
Previous filing
14 Feb 2023
Next filing
13 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common stock Other $34,860 +581,000 +7.5% $0.0600* 8,279,277 31 Mar 2023 Direct F1
transaction NBIO Common stock Purchase $5,200 +130,000 +1.6% $0.0400* 8,409,277 07 Jun 2023 Direct
holding NBIO Common stock 2,000,000 31 Mar 2023 Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.